当前位置:首页 - 行情中心 - 华厦眼科(301267) - 财务分析

华厦眼科

(301267)

  

流通市值:123.33亿  总市值:159.77亿
流通股本:6.48亿   总股本:8.40亿

华厦眼科(301267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.56亿元,每股收益0.52元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益620834.50万元,未分配利润264354.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产816313.08万元,负债195478.58万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,271,797,099.42,138,913,3701,093,056,547.554,027,010,847.67
营业总成本2,700,081,162.641,754,338,135.17890,717,629.483,453,876,046.72
其他经营收益
营业利润614,861,999.21411,732,477.99219,303,449.11644,450,908.83
利润总额579,988,215.19386,990,225.88210,710,799.49563,169,985.43
净利润456,066,099.99300,327,698.5165,298,507.95428,215,139.12
每股收益
其他综合收益-624,557.42-616,422.35-197,544.67-819,868.32
综合收益总额455,441,542.57299,711,276.15165,100,963.28427,395,270.8
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计4,917,624,038.84,903,408,761.074,898,393,552.364,789,035,311.56
非流动资产:
非流动资产合计3,245,506,762.223,264,506,935.53,181,387,671.133,135,007,920.08
资产总计8,163,130,801.028,167,915,696.578,079,781,223.497,924,043,231.64
流动负债:
流动负债合计1,092,328,897.281,249,682,303.991,038,496,553.661,030,016,826.54
非流动负债:
非流动负债合计862,456,864.68855,401,376.78902,706,135.15870,570,443.2
负债合计1,954,785,761.962,105,083,680.771,941,202,688.811,900,587,269.74
所有者权益(或股东权益):
归属于母公司股东权益合计5,998,641,817.345,846,972,181.995,899,996,693.775,794,409,772.57
股东权益合计6,208,345,039.066,062,832,015.86,138,578,534.686,023,455,961.9
负债和股东权益合计8,163,130,801.028,167,915,696.578,079,781,223.497,924,043,231.64
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计3,331,087,546.32,163,412,620.171,075,480,629.944,292,667,147.38
经营活动现金流出小计2,632,976,856.621,739,539,436.78850,880,654.123,472,368,326.1
经营活动产生的现金流量净额698,110,689.68423,873,183.39224,599,975.82820,298,821.28
投资活动产生的现金流量:
投资活动现金流入小计6,460,499,929.454,346,961,600.541,587,643,652.218,086,333,977.84
投资活动现金流出小计9,327,290,666.346,876,666,079.924,349,222,278.628,833,835,526.92
投资活动产生的现金流量净额-2,866,790,736.89-2,529,704,479.38-2,761,578,626.41-747,501,549.08
筹资活动产生的现金流量:
筹资活动现金流入小计30,190,000190,000190,00014,831,000
筹资活动现金流出小计421,524,969.96173,427,187.4571,573,335.91520,983,294.53
筹资活动产生的现金流量净额-391,334,969.96-173,237,187.45-71,383,335.91-506,152,294.53
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-2,560,015,017.17-2,279,068,483.44-2,608,361,986.5-433,355,022.33
期末现金及现金等价物余额909,526,296.291,190,472,830.02861,215,851.053,469,541,313.46
补充资料:
现金及现金等价物的净增加额--2,279,068,483.44--433,355,022.33
最新报告期:2025-11-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西部证券陆伏崴0.590.690.792025-11-19
长江证券彭英骐,徐晓欣0.650.760.872025-11-12
华创证券郑辰,王宏雨0.530.580.652025-11-05
中金公司张一弛,李千翊0.570.66--2025-10-30
中信建投刘慧彬,王在存,贺菊颖0.570.650.712025-10-12
TOP↑